Clinical Trial Results:
A multicentre randomised placebo-controlled double-blind clinical trial for evaluation of safety and efficacy of a specific immunotherapy with an aluminium hydroxide adsorbed allergoid preparation of house dust mites of Dermatophagoides pteronyssinus in patients with rhinitis/rhinoconjunctivitis with or without allergic asthma bronchiale
Summary
|
|
EudraCT number |
2009-014036-37 |
Trial protocol |
PL BG ES |
Global completion date |
24 Jun 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Nov 2016
|
First version publication date |
10 Nov 2016
|
Other versions |
|
Summary report(s) |
Synopsis_AL0907ac abbreviated |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.